No Erthang, you heard him correct the first time. I was aware of your correction and you made a mistake. Dynamics in fact make total sense.
Read it again twice. The first time put "amex" in, the next time put "therapeutics" in. You will see that therapeutics is absolutely what he is talking about and my take gives you a big hint about the direction he wants the company to go.
Read each of these versions and see which one makes sense. Remember, Dr. Moro is a scientist and he does not speak in the same terms as we do but he also doesn't speak gibberish and if you put AMEX in, it just does not flow correctly. If you still have the tape, listen again or have someone else listen. I will bet big time that you were correct the first time with dynamics. Also since he did say AMEX later in the interview, compare the two words. Also you don't get "into" the AMEX but "onto" the Amex.
******
Dr. Moro)Well, we'll see what happens when we go off the pinks. Personally, I think we will get a little bump when we go to the OTC, nothing significant. We are working on and close to getting financing for millions of dollars (we are talking to a number of people about that), then getting into "therapeutics". After we get into "therapeutics", we need to raise about 4 million dollars. I'm close to getting revenue from Abbott for royalties. It holds me back a little bit in terms of, why increase the share base of the company when we can get our money from Abbott? But I need to move to AMEX, or the Nasdaq (small cap), we can get out even from the bulletin board. At that time we are going to have a very, very different credibility and access to additional money that there is no way we have access to so far.
********
Dr. Moro)Well, we'll see what happens when we go off the pinks. Personally, I think we will get a little bump when we go to the OTC, nothing significant. We are working on and close to getting financing for millions of dollars (we are talking to a number of people about that), then getting into "AMEX". After we get into "AMEX", we need to raise about 4 million dollars. I'm close to getting revenue from Abbott for royalties. It holds me back a little bit in terms of, why increase the share base of the company when we can get our money from Abbott? But I need to move to AMEX, or the Nasdaq (small cap), we can get out even from the bulletin board. At that time we are going to have a very, very different credibility and access to additional money that there is no way we have access to so far.
News 
Market Data 
Discover 
AI
